COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases
- PMID: 32503860
- DOI: 10.1136/annrheumdis-2020-218008
COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases
Keywords: outcome and process assessment, health care; outcome assessment, health care; quality indicators, health care.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al.Ann Rheum Dis. 2021 Apr;80(4):e51. doi: 10.1136/annrheumdis-2020-218070. Epub 2020 Jun 5. Ann Rheum Dis. 2021. PMID: 32503850 No abstract available.
Comment on
-
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.Ann Rheum Dis. 2020 Oct;79(10):1382-1383. doi: 10.1136/annrheumdis-2020-217717. Epub 2020 May 12. Ann Rheum Dis. 2020. PMID: 32398281 No abstract available.